Kiran Siddiqui
Child & Adolescent Psychiatry · Tucson, AZNPI 1558474817
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 28.6% of the total.
Across 231 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Corium, LLC$727
- Supernus Pharmaceuticals, Inc.$430
- Johnson & Johnson$376
- Tris Pharma Inc$371
- Ironshore Pharmaceuticals Inc.$261
- plus $991 from 16 others
What the payments were for
- Food & beverage$4,418100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $1,262 |
| Corium, LLC | 36 | $727 |
| Supernus Pharmaceuticals, Inc. | 19 | $430 |
| Johnson & Johnson | 11 | $376 |
| Tris Pharma Inc | 20 | $371 |
| Ironshore Pharmaceuticals Inc. | 15 | $261 |
| Axsome Therapeutics, Inc. | 8 | $154 |
| Vertical Pharmaceuticals, LLC | 8 | $140 |
| Neos Therapeutics, LP | 8 | $136 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $97 |
| Noven Therapeutics, LLC | 3 | $66 |
| Brainsway USA Inc | 1 | $64 |
| Idorsia Pharmaceuticals US Inc | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Neuronetics, Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Shire North American Group Inc | 2 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Tempus AI, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,418 in reported general payments places this provider in the 85th percentile of 80 child & adolescent psychiatry providers in Arizona.
See all child & adolescent psychiatry providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 12 | $253 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Tucson
- Peter KlingerTucson$4K
- Sutapa DubeTucson$441
- Everett RogersTucson$264
- John LeipsicTucson$188
- Suzanne DonPhoenix$119K
- Ramiro GuillenScottsdale$31K
- Edward KuhnleyPrescott Valley$18K
- Jason FridayGilbert$18K
- Linda KalivasScottsdale$13K
- Palpu HazelScottsdale$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.